Baxter International | BAX - Capital Ordinaire





Capital Ordinaire Changement Date
Abbott USD 1.74B 2.94M 2026-03
AngioDynamics USD 41.57M 127K 2025-09
Artivion USD 47.84M 468K 2025-12
AtriCure USD 50.64M 7K 2026-06
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 190.1M 5.01M 2026-06
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
Fresenius EUR 563.24M 0 2026-06
Globus Medical USD 135.67M 611K 2026-03
Halozyme Therapeutics USD 114.04M 4.48M 2026-06
ICU Medical USD 24.99M 305K 2026-03
Inogen USD 23K 0 2023-12
Insulet USD 69.35M 87K 2026-06
Integra LifeSciences USD 77.78M 39K 2026-06
Intuitive Surgical USD 353.28M 885K 2026-09
J&J USD 2.41B 1.64M 2026-06
Laboratory Of America USD 80.9M 1.4M 2026-06
Medtronic USD 1.28B 130K 2026-06
Merit Medical Systems USD 59.71M 55K 2026-06
Quest Diagnostics USD 110M 0 2026-09
Smith & Nephew USD 875.95M 11.64K 2026-06
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.54M 1.04M 2026-06
Teleflex USD 42.37M 1.89M 2026-06
Terumo JPY 1.48B 19K 2026-06
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06